The India Pharmaceutical Report

PRLog (Press Release) - Jun 24, 2007 -
In 2005, India ranked eleventh in the global pharmaceutical market in dollar terms with a global market share of 1.41%. According to the 2005 Espicom World Pharmaceutical Market Fact book, the industry in India was valued at USD 8.8bn with a growth rate of 7.2% Y-o-Y. The Indian pharmaceutical industry traditionally relied on ‘reverse engineering’ i.e. product copying, through which vast profits were made. In recent years, however, the larger domestic companies have realized the need to undertake original research and/or penetrate into the regulated generics markets in the USA/EU in order to survive in the global market. At the same time, the Indian industry is renowned for supplying affordable generic versions of patented drugs for illnesses like HIV/AIDS to some of the world’s poorest counties.

Scope of this report

Our India Pharmaceutical report provides in-depth analysis, built on 2004 and 2005 year-end market data, and updated statistics for Q1-Q2 2006. Packed with tables and graphs from our own CEIC statistics databases, and expert views from our own on-the-ground analysts, this report delivers a thorough yet easily digested overview of the Indian Pharmaceutical market, keeping you up to speed and ahead of the curve on   industry developments.

For more information, Please visit :
http://www.bharatbook.com/detail.asp?id=26467